Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021

SELL
$5.02 - $7.05 $13,428 - $18,858
-2,675 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$4.81 - $10.34 $12,866 - $27,659
2,675 New
2,675 $19,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Stuart Chaussee & Associates, Inc. Portfolio

Follow Stuart Chaussee & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stuart Chaussee & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stuart Chaussee & Associates, Inc. with notifications on news.